Catalytic asymmetric total synthesis of diazabicyclooctane β-lactamase inhibitors avibactam and relebactam

The first catalytic asymmetric total synthesis of marketed DBO β-lactamase inhibitors avibactam and relebactam has been achieved via a Rh-catalysed asymmetric hydrogenation along with multiple flow procedures.